Thyroid cancer: An overview

Nuclear Medicine Communications

Volumn 25, Issue 9, 2004, Pages 861-867

  Haq, Masud ^a   Harmer, Clive ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Anaplastic cancer; Differentiated thyroid cancer; Medullary carcinoma; Radioiodine ablation; Radioiodine therapy; Thyroid lymphoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FLUORODEOXYGLUCOSE F 18; IODINE 131; LIOTHYRONINE; OCTREOTIDE; PENTETREOTIDE IN 111; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; RETINOIC ACID; SUCCIMER TC 99M; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ACUTE LEUKEMIA; ANAPLASTIC CARCINOMA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHERNOBYL ACCIDENT; CONFERENCE PAPER; DOSE RESPONSE; DRUG MEGADOSE; DRUG TOLERABILITY; FOLLICULAR CARCINOMA; GONAD DYSFUNCTION; HUMAN; LUNG FIBROSIS; LYMPHOMA; METASTASIS; NAUSEA; ONCOCYTOMA; PAPILLARY CARCINOMA; SARCOMA; SIALOADENITIS; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; XEROSTOMIA;

CLINICAL TRIALS; HUMANS; IODINE RADIOISOTOPES; NEOPLASM RECURRENCE, LOCAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 4444242256     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-200409000-00001     Document Type: Conference Paper

References (28)

1. British Thyroid Association. Guidelines for the Management of Thyroid Cancer in Adults. London: Royal College of Physicians; 2002.
2. Coleman P, Babb P, Damiecki P, Grosclaude P, Honjo S, Joans J, et al. Cancer Survival Trends in England and Wales 1975-1995: Deprivation and NHS Region. (Series SMPS.) London: Stationery Office Ltd, 1999; pp. 471-478.
3. Stiller CA. Thyroid cancer following Chernobyl. Eur J Cancer 2001; 37:945-947.
4. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141:259-277.
5. Suarez H, Du Villard J, Caillou B, Schlumberger M, Tubiana M, Parmentier C, Monier R. Detection of activated ras oncogenes in human thyroid carcinoma. Oncogene 1988; 5:403-406.
6. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996; 83:1674-1683.
7. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93:359-362.
8. Hamburger JI. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 1994; 79:335-339.
9. Ashcraft MW, Van Herle AJ. Management of thyroid nodules II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg 1981; 3:297-322.
10. Vini L, A'Hern R, Fisher C, Harmer C. Differentiated thyroid cancer: the Royal Marsden experience. Br J Cancer 1999; 8(suppl 2):112 (P336).
11. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-428.
12. Simpson J, Panzarella T, Carruthers J, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988; 83:553-559.
13. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112:1139-1146.
14. O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 1994; 30A:733-739.
15. Vini L, Fisher C, A'Hern R, Harmer C. Hurthle cell cancer of the thyroid: the Royal Marsden experience. Thyroid 1998; 8:1288.
16. Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 1998; 138:249-252.
17. Powell S, Harmer C. Thyroid cancer causing death after 40 years: rationale for initial intensive treatment. Eur J Surg Oncol 1990; 16:457-461.
18. Schlumberger M, Ricard M, Pacini F. Clinical use of recombinant human TSH in thyroid cancer patients. Eur J Endocrinol 2000; 143:557-563.
19. Protopapas AD, Nicholson AG, Vini L, Harmer CL, Goldstraw P. Thoracic metastasectomy in thyroid malignancies. Ann Thorac Surg 2001; 72:1906-1908.
20. Grunwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R, et al. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 1998; 39:1903-1906.
21. O'Connell ME, Flower MA, Hinton PJ, Harmer CL, McCready VR. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993; 28:16-26.
22. Hyer S, Vini L, O'Connell M, Pratt B, Harmer C. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol 2002; 56:755-758.
23. Vini L, Hyer S, Al Saadi A, Pratt B, Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002; 78:92-93.
24. de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 1997; 75:734-739.
25. Fersht N, Vini L, A'Hern R, Harmer C. The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer. Thyroid 2001; 11:1161-1168.
26. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 1994; 74:1348-1354.
27. Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993; 3:93-99.
28. Laing RW, Hoskin P, Hudson BV, Hudson GV, Harmer C, Bennett MH, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 1994; 6:300-304.